Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utility of repeat genotypic resistance testing and clinical response in patients with three class resistance and virologic treatment failure.

AIDS patient care and STDs - 1 Aug 2007

Badri Sheila M, Adeyemi Oluwatoyin M, Max Blake E, Hota Bala N, Barker David E

Abstract excerpt

We sought to determine the utility of repeat genotypic resistance testing (GRT) and the clinical response in HIV-1-infected patients with known resistance to three of the major classes of antiretroviral drugs. The HIV-1 genetic sequences for 20 patients who had high-level 3 class resistance demonstrated on a prior GRT (3C-GRT 1) measured during the period from November 1, 2000 through July 1, 2004 were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Drug Therapy, Combination

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Reverse Transcriptase Inhibitors

Share to Treatment Failure

Source

Identifiers

PMID: 17711379
DOI: 10.1089/apc.2006.0156

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utility of repeat genotypic resistance testing and clinical response in patients with three class resistance and virologic treatment failure.PMID 17711379Read ↗

HIV drug resistance interpreted by cumulative versus last genotypes in HIV-infected patients with multiple treatment failures.Semantic proximity Read ↗

Historical resistance profile helps to predict salvage failure.Semantic proximity Read ↗

Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure.Semantic proximity Read ↗

Plasma HIV RNA decline and emergence of drug resistance mutations among patients with multiple virologic failures receiving resistance testing-guided HAART.Semantic proximity Read ↗

Persistence of earlier HIV-1 drug resistance mutations at new treatment failure.Semantic proximity Read ↗

Extent of human immunodeficiency virus type 1 drug resistance as a predictor of virological failure after genotype-guided treatment switch.Semantic proximity Read ↗

Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml.Semantic proximity Read ↗

[Clinical use of HIV-1 resistance genotyping. Predictive factors of poor virological evolution in salvage treatments].Semantic proximity Read ↗

Use of HIV resistance testing after prolonged treatment interruption.Semantic proximity Read ↗

Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy.Semantic proximity Read ↗

Clinical utility of genotypic resistance tests for HIV-1-infected patients with low-level virological failure.Semantic proximity Read ↗

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.